We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI-Powered Software Aims to Achieve 6x Reduction in Radiation Dose of Fluoroscopy Exams

By HospiMedica International staff writers
Posted on 09 Feb 2022

An innovative artificial intelligence (AI)-powered software uses deep learning (DL) to reduce radiation dosage needed during fluoroscopy exams. More...

Subtle Medical, Inc. (Menlo Park, CA, USA) has been awarded an NIH SBIR grant to develop the AI-powered software, SubtleIR, in line with the company's mission to accelerate access to faster, safer, and smarter medical imaging. This is the second NIH SBIR grant awarded to Subtle. The first was for SubtleGAD, an AI-based software using deep learning to drastically reduce contrast dosage needed during contrast-enhanced medical imaging exams.

Fluoroscopy is a common tool for image-guided interventions in surgeries. The new software will potentially reduce radiation exposure in the operating room, minimizing the risk of cancer development for both patients and radiology staff. Subtle aims to enhance fluoroscopy videos acquired with up to 83% lower dose levels into videos with full-dose quality. This conversion will be performed in real-time, such that the surgeon can receive video feedback without delay while greatly reducing radiation exposure to both the patient and operating clinicians.

In addition, Subtle aims to optimize the processing speed of these DL models by leveraging various software and hardware accelerations for real-time application to achieve over a 30 fps processing rate, which will enable a seamless integration between video capture and subsequent display. Recent research on SubtleIR's technology was published at MICCAI showing a 4x dose reduction while providing equivalent or better video quality to the normal dosage level, as supported by quantitative metrics and surgeon review.

"Receiving this SBIR grant will allow us to meet the demand for new AI applications that support image guided therapy and surgeries. With this technology, hospitals and imaging centers will be able to deliver safer low-dose fluoroscopy exams without sacrificing the clinical quality of the images," said Enhao Gong, PhD, Co-founder & CEO. "We appreciate the NIH's support in the development of this novel AI product and look forward to deploying it in clinical settings."

Related Links:
Subtle Medical, Inc. 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.